Literature DB >> 10617636

Histone H2B phosphorylation in mammalian apoptotic cells. An association with DNA fragmentation.

K Ajiro1.   

Abstract

Histone phosphorylation was investigated in several mammalian cells undergoing apoptosis (human HL-60 and HeLa, mouse FM3A and N18 cells, and rat thymocytes). Among the four nucleosomal core histones (H2A, H2B, H3, and H4), H2B, which is not usually phosphorylated in quiescent or growing cells, was found to be phosphorylated after treatment with various apoptotic inducers. The H2B was phosphorylated around the time when nucleosomal DNA fragmentation was initiated and, like this fragmentation, was completely blocked with Z-Asp-CH(2)-DCB, an inhibitor of ICE or ICE-like caspase. The involved single phosphopeptide of H2B proved to be phosphorylatable in vitro with a protein kinase C, and the site Ser-32 was tentatively identified. Despite typical apoptotic chromatin condensation, the H3 phosphorylation was at a low level, and the sites where phosphorylation did occur did not include any mitosis-specific phosphopeptides. Phosphorylation of H4 was increased, but the other two histone proteins (H1 and H2A) were not appreciably changed. These observations imply that 1) H2B phosphorylation occurs universally in apoptotic cells and is associated with apoptosis-specific nucleosomal DNA fragmentation, 2) chromatin condensation in apoptosis occurs by a different biochemical mechanism from those operating during mitosis or premature chromosome condensation, and 3) this unique phosphorylation of H2B is a useful biochemical hallmark of apoptotic cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10617636     DOI: 10.1074/jbc.275.1.439

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

1.  Influence of irradiation and pentoxifylline on histone H3 phosphorylation in human tumour cell lines.

Authors:  A Binder; L Bohm
Journal:  Cell Prolif       Date:  2002-02       Impact factor: 6.831

Review 2.  An increasingly complex code.

Authors:  Hugh T Spotswood; Bryan M Turner
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

Review 3.  A peek into the complex realm of histone phosphorylation.

Authors:  Taraswi Banerjee; Debabrata Chakravarti
Journal:  Mol Cell Biol       Date:  2011-10-17       Impact factor: 4.272

Review 4.  Epigenetic modifications and human disease.

Authors:  Anna Portela; Manel Esteller
Journal:  Nat Biotechnol       Date:  2010-10       Impact factor: 54.908

5.  Noise-induced changes in gene expression in the cochleae of mice differing in their susceptibility to noise damage.

Authors:  Michael Anne Gratton; Anna Eleftheriadou; Jerel Garcia; Esteban Verduzco; Glen K Martin; Brenda L Lonsbury-Martin; Ana E Vázquez
Journal:  Hear Res       Date:  2010-12-25       Impact factor: 3.208

6.  Biochemical analysis of MST1 kinase: elucidation of a C-terminal regulatory region.

Authors:  Ruchi Anand; Ah-Young Kim; Michael Brent; Ronen Marmorstein
Journal:  Biochemistry       Date:  2008-06-24       Impact factor: 3.162

7.  Modulation of chromatin by MARs and MAR binding oncogenic transcription factor SMAR1.

Authors:  Kiran K Nakka; Samit Chattopadhyay
Journal:  Mol Cell Biochem       Date:  2009-10-03       Impact factor: 3.396

Review 8.  Quantitative proteomic analysis of histone modifications.

Authors:  He Huang; Shu Lin; Benjamin A Garcia; Yingming Zhao
Journal:  Chem Rev       Date:  2015-02-17       Impact factor: 60.622

9.  Caspase-dependent regulation of histone deacetylase 4 nuclear-cytoplasmic shuttling promotes apoptosis.

Authors:  Gabriela Paroni; Michela Mizzau; Clare Henderson; Giannino Del Sal; Claudio Schneider; Claudio Brancolini
Journal:  Mol Biol Cell       Date:  2004-04-09       Impact factor: 4.138

10.  Reciprocal epigenetic modification of histone H2B occurs in chromatin during apoptosis in vitro and in vivo.

Authors:  K Ajiro; A B Scoltock; L K Smith; M Ashasima; J A Cidlowski
Journal:  Cell Death Differ       Date:  2010-01-08       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.